Showing results (31-40 of 171) with videos related to
Sort By:
Pageof 18
AIDS (London, England)|March 15, 1997
Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion StudyM Dorrucci, P Pezzotti, A N Phillips, et al.AIDS Care|November 26, 1998
HIV infection among foreign people involved in HIV-related risk activities and attending an HIV reference centre in Rome: the possible role of counselling in reducing risk behaviourL Spizzichino, P Casella, M Zaccarelli, et al.AIDS Patient Care and Stds|October 8, 2004
Predictors of survival in children with acquired immunodeficiency syndrome in Italy, 1983 to 1995S T Ciuta, S Boros, P A Napoli, et al.AIDS and Behavior|July 4, 2014
Psychosocial health conditions and HIV prevalence and incidence in a cohort of men who have sex with men in Bangkok, Thailand: evidence of a syndemic effectT E Guadamuz, K McCarthy, W Wimonsate, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 17, 1999
Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion StudyP Pezzotti, N Galai, D Vlahov, et al.Addiction Biology|January 7, 2016
Effects of age, gender, duration of drug use and infection with viral hepatitis B and C on lymphocyte subsets in a population of HIV-negative injecting drug users in ItalyG Rezza, P D'Egidio, A Cozzi Lepri, et al.Sozial- Und Praventivmedizin|January 1, 1994
Assessing HIV prevention among injecting drug users in European Community countries: a reviewG Rezza, M C Rota, E Buning, et al.Cancer|March 1, 1997
Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study GroupD Serraino, P Pezzotti, M Dorrucci, et al.Infection|March 1, 1997
Improving the prognostic value of CD4+ count using IgA and clinical signs in HIV-seropositive i.v. drug usersF Montella, P Pezzotti, F Di Sora, et al.Pageof 18